Barron v. PGA Tour, Inc.

670 F. Supp. 2d 674, 2009 U.S. Dist. LEXIS 107194, 2009 WL 3839476
CourtDistrict Court, W.D. Tennessee
DecidedNovember 16, 2009
Docket09-CV-02733 Ma/P
StatusPublished
Cited by14 cases

This text of 670 F. Supp. 2d 674 (Barron v. PGA Tour, Inc.) is published on Counsel Stack Legal Research, covering District Court, W.D. Tennessee primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Barron v. PGA Tour, Inc., 670 F. Supp. 2d 674, 2009 U.S. Dist. LEXIS 107194, 2009 WL 3839476 (W.D. Tenn. 2009).

Opinion

*677 ORDER DENYING PLAINTIFF’S MOTION FOR TEMPORARY RESTRAINING ORDER

TU M. PHAM, United States Magistrate Judge.

On Thursday, November 12, 2009, plaintiff Stephen Douglas Barron (“Doug Barron” or “Barron”) filed a Verified Complaint for Monetary Damages and Injunctive Relief in the Chancery Court of Tennessee for the Thirteenth Judicial District, in Memphis, Tennessee. In his complaint, Barron seeks, among other relief, a temporary restraining order requiring defendant PGA Tour, Inc. (“PGA Tour”) to allow him to compete in the Second Qualifying Stage of the PGA Tour Qualifying Tournament, which begins on Wednesday, November 18, 2009, at the Deerwood Golf Club in Kingwood, Texas, with practice rounds beginning on Monday, November 16. A hearing on Barron’s motion for a temporary restraining order was scheduled to take place at 2:00 p.m. on November 12 before the Chancery Court. 1 However, the PGA Tour filed a Notice of Removal on the afternoon of November 12, removing the case to the United States District Court for the Western District of Tennessee. The parties later approached the District Judge assigned to the case, stated that they consented to have the Magistrate Judge preside over and decide the motion, and requested an expedited hearing. The parties’ request was granted and a hearing on the motion was scheduled for Friday, November 13, at 9:00 a.m., before the undersigned Magistrate Judge. 2 At the conclusion of the hearing, the court took the motion under advisement.

The court, having now considered the arguments of counsel and the entire record in this case, denies the motion for a temporary restraining order.

I. FINDINGS OF FACT

The following facts are based predominantly on the verified complaint, the affidavit filed by Andrew B. Levinson (Executive Director of the PGA Tour Anti-Doping Program), and exhibits admitted at the hearing. 3

Doug Barron is a professional golfer who joined the PGA Tour in January of 1995. In 1987, when he was eighteen years old, he was diagnosed with mitral valve prolapse and was prescribed a beta blocker, Propranolol, to treat the condition. Without Propranolol, Barron experiences a racing heartbeat and chest pains. In 2005, Barron was found to have low Testoster *678 one levels and was prescribed monthly-doses of exogenous Testosterone in order to maintain his Testosterone level within the normal range. Side effects of low Testosterone can include fatigue, lethargy, loss of sex drive, and a compromised immune system, resulting in an increased incidence of infection.

The PGA Tour, together with corporate sponsors and charitable organizations, organizes golf tournaments through the PGA and Nationwide Tours, and awards prize money to golfers who compete in these tournaments. The PGA Tour establishes rules and policies that govern the conduct of golfers who participate in PGA and Nationwide Tour events. Golfers must pay dues to the PGA Tour and agree to abide by the rules and policies established by the PGA Tour in order to participate in PGA Tour events.

In 2008, the PGA Tour promulgated its Anti-Doping Program (“the Program”), and on July 3, 2008, the Program went into effect. The Program was developed in conjunction with the major golf tours and governing bodies around the world and incorporated input from leading experts in the field of anti-doping. The Program was modeled on the standards of the World Anti-Doping Agency and its Anti-Doping Code.

The Program contains a list of “Prohibited Substances and Methods,” and included on this list of banned substances are Propranolol and exogenous Testosterone. The Program allows players to apply for a Therapeutic Use Exemption (“TUE”). If granted, the TUE allows the player to use the substance despite its status on the list of banned substances. In order to obtain a TUE, the player must submit an application and supporting medical information. This information is submitted to a TUE Committee comprised of an independent medical advisor and one or more independent specialists of the medical advisor’s choosing with experience in the area relevant to the player’s illness or condition. The TUE Committee reviews the medical information and recommends to the PGA Tour whether to grant a TUE. Under the Program, a player may obtain a TUE if four criteria are met:

a. The player would experience a significant impairment to health if the Prohibited Substance or Prohibited Method were to be withheld in the course of treating an acute or chronic medical condition (the use of any Prohibited Substance or Prohibited Method to increase “low-normal” levels of any Endogenous hormone is not considered an acceptable therapeutic intervention); and
b. The therapeutic use of the Prohibited Substance or Prohibited Method would produce no additional enhancement of performance other than that which might be anticipated by a return to a state of normal health following the treatment of a legitimate medical condition; and
c. There is no reasonable therapeutic alternative to the use of the otherwise Prohibited Substance or Prohibited Method; and
d. The necessity for the use of the otherwise Prohibited Substance or Prohibited Method is not a consequence, wholly or in part, of a prior non-therapeutic use of any substance on the PGA Tour Prohibited List.

Prior to the effective date of the Program, on June 23, 2008, Barron submitted two TUE applications to the PGA Tour. The first application sought an exemption for the use of the beta blocker Propranolol. This application was reviewed by a TUE Committee consisting of a panel of doctors, including cardiologists. The application to use Propranolol was denied by the TUE Committee on October 10, 2008. Barron *679 appealed the decision in accordance with the Program and the appeal was denied by the PGA Tour on October 22, 2008. Barron was instructed by the PGA Tour to begin weaning himself off of Propranolol. After his application was denied, Barron began reducing his dosage of Propranolol under a course of treatment prescribed by his medical doctor. He initially started the treatment with 160 milligrams of Propranolol, and by June of 2009, he had reduced his dosage to 40 milligrams.

The second application for a TUE sought an exemption for the use of Testosterone. This application was reviewed by a TUE Committee consisting of a panel of doctors, including endocrinologists. At the request of the TUE Committee, Barron was reexamined by an independent endocrinologist. At the request of the independent endocrinologist, Barron stopped receiving monthly Testosterone injections in October of 2008. The independent endocrinologist then took Barron’s blood samples in November and December of 2008. The November test indicated Barron’s Testosterone level was 325, while the December test indicated that it was 296.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
670 F. Supp. 2d 674, 2009 U.S. Dist. LEXIS 107194, 2009 WL 3839476, Counsel Stack Legal Research, https://law.counselstack.com/opinion/barron-v-pga-tour-inc-tnwd-2009.